#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypereosinophilic syndrome Skin angiosarcoma Waldenstrom's macroglobulinaemia Epstein-Barr virus infection Short-bowel syndrome Pyruvate kinase deficiency anaemia Chondrodystrophy Acquired C1 inhibitor deficiency Heart disease congenital Interstitial lung disease Amyotrophic lateral sclerosis Rhabdomyosarcoma Liposarcoma recurrent Polycythaemia vera Aplastic anaemia More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Trials in Disease IgA nephropathy – Trials in Disease Crigler-Najjar syndrome MELAS syndrome Malignant fibrous histiocytoma – Basic Information Progressive multifocal leukoencephalopathy – Diagnostics Osteosarcoma recurrent – Treatment Lysosomal storage disorder – Trials in Disease Splenic marginal zone lymphoma – Treatment Marginal zone lymphoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Neratinib Dalbavancin Levodopa Imipenem Monohydrate Abatacept Sodium Valproate ALKYLATING AGENTS Methoxyflurane IMA401 Metronidazole Ziclumeran Pentosan Polysulfate Sodium GEN1078 Tamoxifen Citrate Emiplacel Xaluritamig Azd7798 Lorlatinib Ng004 Intestifix More therapies…

    Learn about Your Condition

    Primary hypercholesterolaemia Primary hyperoxaluria Arthroscopy Thalassaemia alpha Hypersensitivity Acquired ATTR amyloidosis Cerebral palsy Skin wrinkling Metastases to lymph nodes Primary hyperthyroidism Colon cancer stage IV Synovial sarcoma metastatic Toxic nodular goitre HER2 positive gastric cancer Biopsy heart More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colitis ulcerative

  • Study of Oral NX-13 for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • 1,3,5-Tris(6-Methylpyridin-2-Yloxy)Benzene
    Belgium Italy Poland

  • Study on VE202 for Patients with Mild-to-Moderate Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Bacilli, Cluster Xviii, Strain Relative Thomasclavelia Ramosum, Live
    • Bacilli, Cluster Xviii, Strain Relative Thomasclavelia Sp000508865, Live
    • Clostridia, Cluster Iv, Strain Relative Anaerotruncus Colihominis, Live
    Bulgaria Czechia Hungary Lithuania The Netherlands Poland

  • Study on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Morf-057
    Poland

  • Study of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Ro7790121
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Study of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Austria Belgium Bulgaria Croatia Czechia Denmark +10
Previous Page
1 … 18 19 20

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!